Contango Oil & Gas Co. (MCF) Jumps 8.19% on January 21

Equities Staff |

Contango Oil & Gas Co. (MCF) was among the biggest gainers on the Russell 2000 for Thursday January 21 as the stock popped 8.19% to $4.49, representing a gain of $0.34 per share. Some 77,787 shares traded hands on 632 trades, compared with an average daily volume of 144,215 shares out of a total float of 19.4 million. The stock opened at $4.13 and traded with an intraday range of $4.65 to $4.13.

After today's gains, Contango Oil & Gas Co. reached a market cap of $87.12 million. Contango Oil & Gas Co. has had a trading range between $33.17 and $3.68 over the last year, and it had a 50-day SMA of $6.61 and a 200-day SMA of $10.92.

Contango Oil & Gas Company is an independent energy company. It is engaged in the exploration, development, production and acquisition of crude oil, natural gas and natural gas liquids reserves in the Gulf of Mexico.

Contango Oil & Gas Co. is based out of Houston, TX and has some 92 employees. Its CEO is Allan D. Keel.

For a complete fundamental analysis analysis of Contango Oil & Gas Co., check out’s Stock Valuation Analysis report for MCF. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Relevium Technologies Inc.

Relevium Technologies Inc is engaged in the acquisition of products, technologies and businesses relating to musculoskeletal function, specifically Pain Relief, Injury Recovery and Active Performance.

Private Markets

BioSculpture Technology, Inc.

BioSculpture Technology, Inc. (“BST”) is a commercial-stage medical device manufacturer of liposuction surgical instruments for surgeons. It offers the FDA-cleared Twin Cannula Assisted Liposuction ("TCAL") Airbrush Liposculptor II® controllers, Airbrush®…


Trustify provides trust and safety in both the digital and physical worlds through our vast network of on-demand Private Investigators.By removing the large retainers and high hourly rates that traditional…